H.C. Wainwright BioConnect 2021 Conference
Join us for presenting companies, fireside discussions, meetings with H.C. Wainwright investment banking & research teams, and an evening of virtual entertainment.
Join us for presenting companies, fireside discussions, meetings with H.C. Wainwright investment banking & research teams, and an evening of virtual entertainment.
BIO One-on-One Partnering is your virtual partnering and business development companion, with integrated video conferencing and more biotechnology-specific search filters & therapeutic categories than any other major platform to help you target potential partners faster than ever. Learn more about BIO One-on-One Partnering → Participating in BIO @ JPM Week provides you access to the biotech business...
2020 is history: Where do pharma and healthcare go from here? Every January, the J.P. Morgan Healthcare Conference in San Francisco has been a news-breaking, people-watching, dealmaking bazaar that sets the tone for the year to come—and Fierce has brought together a who's who of experts and executives on the sidelines. This year, the meeting's...
This year, as part of the virtual version of J.P. Morgan Week, our team of Life Sciences & Healthcare experts will support French companies during this investor week. With a privileged and discounted access to the main events of the week, introductions to investors, masterclasses and a pitch session with international players in the pharmaceutical,...
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs,...
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
Biotech Showcase: San Francisco's Exclusive Investor and Networking Event - Innovation meets money during biotech's most impactful week of the year. Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one...
The first edition of World Chemistry Conference and Exhibition (WCCE) was born in Rome, Italy aiming to serve as a premier forum for the presentation of technological advances and research results in the fields of chemistry, engineering and applied sciences. The second edition WCCE was held in Valencia, Spain in July of 2018. The third...
The 34th EAST Annual Scientific Assembly – Virtual #EAST2021 will include more than 50 scientific paper presentations and named lectures. Mark your calendar for this two-day program that will feature excellent science and educational sessions. CME will be available. Registration will open in December, 2020. Acknowledging the financial impact on nearly all healthcare systems, registration pricing has been...
The 16th Annual Non-Dilutive Funding Summit is a free educational, all-day event that brings together hundreds of life science industry leaders to learn from various non-dilutive funding sources about their interests, goals, and funding objectives.
The health and safety of the global oncology community and the patients we serve remains our top priority. As concerns and uncertainty regarding the safety of individual travel and large group gatherings related to the COVID-19 pandemic continue, the Gastrointestinal Cancers Symposium cosponsors have decided to host the 2021 meeting as a virtual event January 15-17,...
RNA interference (RNAi) therapeutics are emerging as an important class of human medicines due to their ability to harness a natural cellular mechanism that can potentially regulate the expression of any RNA transcript. The first RNAi therapeutics recently entered commercial stage after gaining regulatory approval, and several others are currently in late stage clinical development....